Orajel 2x Medicated Gel
NDC Package 10237-782-25
Package Information
Orajel 2x Medicated Gel (oral pain reliever) gel is cut open tip of tube on score markAdults and children 2 years of age and over: apply to affected area up to 4 times daily or as directed by a dentist or doctorChildren between 2 and 12 years of age: ask a doctor before use. This formulation utilizes a gel delivery system. Marketed by Church & Dwight Co., Inc., this product is identified by NDC 10237-782 and is authorized under FDA application M022.
Identification & Billing
- RxCUI: 2117337 - benzocaine 20 % / menthol 0.26 % Oral Gel
- RxCUI: 2117337 - benzocaine 0.2 MG/MG / menthol 0.0026 MG/MG Oral Gel
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 10237 - Church & Dwight Co., Inc.
- 10237-782 - Orajel 2x Medicated Gel
- 10237-782-25 - 1 TUBE in 1 CARTON / 7 g in 1 TUBE
- 10237-782 - Orajel 2x Medicated Gel
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (10237-782). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 10237-782-25 identifies a specific commercial package of 1 tube in 1 carton / 7 g in 1 tube of Orajel 2x Medicated Gel, a human over the counter drug labeled by Church & Dwight Co., Inc.. This gel is formulated for topical use and contains benzocaine; menthol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Church & Dwight Co., Inc. on May 23, 2022. The current certification is valid through December 31, 2026.
How is this Church & Dwight Co., Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 10237078225. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.